XML 32 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1

Marketable Investment Securities

12 Months Ended

Dec. 31, 2021

Investments, Debt and Equity Securities [Abstract]

Marketable Investment Securities

(3) Marketable Investment Securities

The Company has classified its marketable investment securities as available-for-sale securities, all of which are debt securities. These securities are carried at fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive income (loss) in stockholders’ equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend income is recognized on the ex-dividend date and interest income is recognized on an accrual basis. The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at December 31, 2021 and 2020 were as follows:

 Schedule of Available-for-Sale Securities

December 31, 2021		Amortized Cost				Gross unrealized holding gains				Gross unrealized holding losses				Aggregate fair value
Government treasury bills		$	5,526,122			$	-			$	(10,202	)		$	5,515,920
Corporate bonds, notes and commercial paper			38,181,099				-				(7,814	)			38,173,285
		$	43,707,221			$	-			$	(18,016	)		$	43,689,205

December 31, 2020		Amortized Cost				Gross unrealized holding gains				Gross unrealized holding losses				Aggregate fair value
Commercial paper		$	449,992				-				-			$	449,992
		$	449,992			$	-			$	-			$	449,992

LIPOCINE INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2021 and 2020

(3) Marketable Investment Securities - (continued)

Maturities of debt securities classified as available-for-sale securities at December 31, 2021 are as follows:

 Schedule of Maturities of Debt Securities Classified as Available-for-sale Securities

December 31, 2021		Amortized Cost				Aggregate fair value
Due within one year		$	41,680,635			$	41,667,405
Due after one year through two years			2,026,586				2,021,800
		$	43,707,221			$	43,689,205

There were no sales of marketable investment securities during the years ended December 31, 2021 and 2020 and therefore no realized gains or losses. Additionally, $4.7 million and $10.2 million of marketable investment securities matured during the years ended December 31, 2021 and 2020, respectively. The Company determined there were no other-than-temporary impairments for the years ended December 31, 2021 and 2020.

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2209399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2324412

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-URI http://asc.fasb.org/topic&trid=2196928

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2176304

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher SEC
-Name Regulation S-K (SK)
-Number 229
-Section 1403
-Paragraph (b)

+ Details

Name:	us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration